Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Midwestern University describes isotopically stabilized tetronimide compounds

Sep. 7, 2020

S-62798 demonstrates efficacy in mouse model of thromboembolism

Sep. 7, 2020

University of California patents lentiviral vectors for hemoglobinopathies

Sep. 4, 2020

LNP-023 demonstrates efficacy, both as add-on and monotherapy, in patients with PNH

Sep. 3, 2020

Bristol-Myers Squibb reports phase I data for the antithrombotic milvexian

Sep. 2, 2020

First clinical data for TAFIa inhibitor S-62798 presented

Sep. 2, 2020

FDA clears IND for clinical development of OMS-906 for PNH

Sep. 1, 2020

Discovery of novel HIF-PHD2 inhibitors for the treatment of anemia

Sep. 1, 2020

Early clinical reports suggest utility of Aggrastat for COVID-19-related thrombotic complications

Aug. 25, 2020

BioMarin receives complete response letter from FDA for valoctocogene roxaparvovec

Aug. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.